Our investigation revealed that predominantly estrogen receptor beta (ERβ) and not estrogen receptor alpha (ERα) are present in cutaneous melanoma (CM) [20,21,28,31]. This evidence concerns the gene ESR2 and cutaneous mastocytosis.